| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Wnt receptor activity | 1.02e-14 | 17 | 52 | 7 | GO:0042813 | |
| GeneOntologyMolecularFunction | Wnt-protein binding | 2.72e-12 | 34 | 52 | 7 | GO:0017147 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 3.01e-08 | 123 | 52 | 7 | GO:0030165 | |
| GeneOntologyMolecularFunction | ubiquitin-like ligase-substrate adaptor activity | 6.97e-08 | 82 | 52 | 6 | GO:1990756 | |
| GeneOntologyMolecularFunction | enzyme-substrate adaptor activity | 1.69e-07 | 95 | 52 | 6 | GO:0140767 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 3.10e-07 | 55 | 52 | 5 | GO:0042974 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 1.25e-05 | 875 | 52 | 11 | GO:0019904 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 1.24e-04 | 187 | 52 | 5 | GO:0016922 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 7.23e-04 | 417 | 52 | 6 | GO:0061629 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 2.39e-03 | 102 | 52 | 3 | GO:0001540 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TAF6L VPS18 PRAMEF9 SND1 PRAMEF14 PRAMEF15 PRAMEF4 PRAMEF13 PRAMEF11 | 2.80e-03 | 1160 | 52 | 9 | GO:0030674 |
| GeneOntologyBiologicalProcess | non-canonical Wnt signaling pathway | 1.03e-09 | 77 | 53 | 7 | GO:0035567 | |
| GeneOntologyBiologicalProcess | somatic stem cell population maintenance | 3.37e-07 | 108 | 53 | 6 | GO:0035019 | |
| GeneOntologyBiologicalProcess | T cell differentiation in thymus | 4.64e-07 | 114 | 53 | 6 | GO:0033077 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | FZD1 FZD4 FZD7 FZD8 BMP2 FZD3 SULF1 FZD5 PRAMEF14 PRAMEF15 PRKAR1A PRKDC PRAMEF4 PRAMEF13 FZD2 PRAMEF11 | 5.46e-07 | 1483 | 53 | 16 | GO:0048646 |
| GeneOntologyBiologicalProcess | Wnt signaling pathway | 6.53e-07 | 516 | 53 | 10 | GO:0016055 | |
| GeneOntologyBiologicalProcess | blastocyst formation | 1.69e-06 | 78 | 53 | 5 | GO:0001825 | |
| GeneOntologyBiologicalProcess | embryo development | FZD1 FZD7 BMP2 FZD3 SULF1 FZD5 PRAMEF14 PRAMEF15 PRKAR1A PADI6 PRKDC PRAMEF4 PRAMEF13 FZD2 PRAMEF11 | 2.06e-06 | 1437 | 53 | 15 | GO:0009790 |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 2.38e-06 | 237 | 53 | 7 | GO:0019827 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | FZD1 BMP2 FZD3 SULF1 FZD5 PRAMEF14 PRAMEF15 PRKDC PRAMEF4 PRAMEF13 FZD2 PRAMEF11 | 2.42e-06 | 906 | 53 | 12 | GO:0043009 |
| GeneOntologyBiologicalProcess | canonical Wnt signaling pathway | 2.54e-06 | 344 | 53 | 8 | GO:0060070 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 2.73e-06 | 242 | 53 | 7 | GO:0098727 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | FZD1 BMP2 FZD3 SULF1 FZD5 PRAMEF14 PRAMEF15 PRKDC PRAMEF4 PRAMEF13 FZD2 PRAMEF11 | 3.14e-06 | 929 | 53 | 12 | GO:0009792 |
| GeneOntologyBiologicalProcess | MAPK cascade | FZD4 FZD7 FZD8 BMP2 FZD5 PRAMEF14 PRAMEF15 LRP1 PRAMEF4 PRAMEF13 PRAMEF11 ITPKB | 3.17e-06 | 930 | 53 | 12 | GO:0000165 |
| GeneOntologyBiologicalProcess | oocyte development | 5.50e-06 | 99 | 53 | 5 | GO:0048599 | |
| GeneOntologyBiologicalProcess | regulation of MAPK cascade | FZD4 FZD7 FZD8 BMP2 FZD5 PRAMEF14 PRAMEF15 LRP1 PRAMEF4 PRAMEF13 PRAMEF11 | 5.72e-06 | 815 | 53 | 11 | GO:0043408 |
| GeneOntologyBiologicalProcess | oocyte differentiation | 6.68e-06 | 103 | 53 | 5 | GO:0009994 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | FZD7 BMP2 PRAMEF25 PRAMEF9 PRAMEF14 PRAMEF15 EIF2AK4 PRAMEF4 PRAMEF13 PRAMEF11 ITPKB | 1.12e-05 | 875 | 53 | 11 | GO:0045596 |
| GeneOntologyBiologicalProcess | Wnt signaling pathway, planar cell polarity pathway | 1.20e-05 | 55 | 53 | 4 | GO:0060071 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process | FZD1 PRAMEF25 PRAMEF9 FZD3 PRAMEF14 PRAMEF15 LRP1 PRKDC PRAMEF4 PRAMEF13 PRAMEF11 ITPKB | 2.34e-05 | 1133 | 53 | 12 | GO:0043066 |
| GeneOntologyBiologicalProcess | negative regulation of programmed cell death | FZD1 PRAMEF25 PRAMEF9 FZD3 PRAMEF14 PRAMEF15 LRP1 PRKDC PRAMEF4 PRAMEF13 PRAMEF11 ITPKB | 3.23e-05 | 1171 | 53 | 12 | GO:0043069 |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | FZD7 BMP2 PRAMEF25 PRAMEF9 SULF1 PRAMEF14 PRAMEF15 EIF2AK4 PRAMEF4 PRAMEF13 PRAMEF11 ITPKB | 4.83e-05 | 1220 | 53 | 12 | GO:0051093 |
| GeneOntologyBiologicalProcess | oogenesis | 4.97e-05 | 156 | 53 | 5 | GO:0048477 | |
| GeneOntologyBiologicalProcess | regulation of ERK1 and ERK2 cascade | 5.50e-05 | 385 | 53 | 7 | GO:0070372 | |
| GeneOntologyBiologicalProcess | ERK1 and ERK2 cascade | 9.21e-05 | 418 | 53 | 7 | GO:0070371 | |
| GeneOntologyBiologicalProcess | blastocyst development | 9.53e-05 | 179 | 53 | 5 | GO:0001824 | |
| GeneOntologyBiologicalProcess | muscular septum morphogenesis | 9.65e-05 | 6 | 53 | 2 | GO:0003150 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway, calcium modulating pathway | 1.35e-04 | 7 | 53 | 2 | GO:0007223 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | FZD7 BMP2 PRAMEF25 PRAMEF9 FZD3 PRAMEF14 PRAMEF15 PRKDC PRAMEF4 PRAMEF13 PRAMEF11 | 1.83e-04 | 1190 | 53 | 11 | GO:0008284 |
| GeneOntologyBiologicalProcess | regulation of animal organ morphogenesis | 1.83e-04 | 110 | 53 | 4 | GO:2000027 | |
| GeneOntologyBiologicalProcess | establishment of planar polarity | 1.97e-04 | 44 | 53 | 3 | GO:0001736 | |
| GeneOntologyBiologicalProcess | establishment of tissue polarity | 2.11e-04 | 45 | 53 | 3 | GO:0007164 | |
| GeneOntologyBiologicalProcess | circulatory system development | FZD1 FZD4 FZD7 FZD8 BMP2 DSG2 SULF1 FZD5 LRP1 PRKAR1A PRKDC FZD2 | 2.37e-04 | 1442 | 53 | 12 | GO:0072359 |
| GeneOntologyBiologicalProcess | female gamete generation | 2.66e-04 | 223 | 53 | 5 | GO:0007292 | |
| GeneOntologyBiologicalProcess | positive regulation of JUN kinase activity | 2.71e-04 | 49 | 53 | 3 | GO:0043507 | |
| GeneOntologyBiologicalProcess | membranous septum morphogenesis | 2.88e-04 | 10 | 53 | 2 | GO:0003149 | |
| GeneOntologyBiologicalProcess | hard palate development | 2.88e-04 | 10 | 53 | 2 | GO:0060022 | |
| GeneOntologyBiologicalProcess | cellular process involved in reproduction in multicellular organism | 3.81e-04 | 527 | 53 | 7 | GO:0022412 | |
| GeneOntologyBiologicalProcess | T cell activation | 3.92e-04 | 701 | 53 | 8 | GO:0042110 | |
| GeneOntologyBiologicalProcess | negative regulation of cardiac muscle cell differentiation | 4.21e-04 | 12 | 53 | 2 | GO:2000726 | |
| GeneOntologyBiologicalProcess | T cell differentiation | 4.27e-04 | 382 | 53 | 6 | GO:0030217 | |
| GeneOntologyBiologicalProcess | pro-B cell differentiation | 4.96e-04 | 13 | 53 | 2 | GO:0002328 | |
| GeneOntologyBiologicalProcess | heart development | 6.51e-04 | 757 | 53 | 8 | GO:0007507 | |
| GeneOntologyBiologicalProcess | negative regulation of cardiocyte differentiation | 6.66e-04 | 15 | 53 | 2 | GO:1905208 | |
| GeneOntologyBiologicalProcess | regulation of establishment of planar polarity involved in neural tube closure | 6.66e-04 | 15 | 53 | 2 | GO:0090178 | |
| GeneOntologyBiologicalProcess | regulation of JUN kinase activity | 6.83e-04 | 67 | 53 | 3 | GO:0043506 | |
| GeneOntologyBiologicalProcess | establishment of planar polarity involved in neural tube closure | 7.60e-04 | 16 | 53 | 2 | GO:0090177 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | 7.90e-04 | 596 | 53 | 7 | GO:0001701 | |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | FZD1 FZD4 FZD7 FZD8 BMP2 FZD5 SIK2 PRKAR1A EIF2AK4 PRKDC ITPKB | 8.27e-04 | 1421 | 53 | 11 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | FZD1 FZD4 FZD7 FZD8 BMP2 FZD5 SIK2 PRKAR1A EIF2AK4 PRKDC ITPKB | 8.37e-04 | 1423 | 53 | 11 | GO:0051174 |
| GeneOntologyBiologicalProcess | morphogenesis of a polarized epithelium | 8.78e-04 | 73 | 53 | 3 | GO:0001738 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-substrate adhesion | 9.13e-04 | 74 | 53 | 3 | GO:0010812 | |
| GeneOntologyBiologicalProcess | establishment of planar polarity of embryonic epithelium | 9.65e-04 | 18 | 53 | 2 | GO:0042249 | |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | 9.94e-04 | 1226 | 53 | 10 | GO:0042325 | |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | FZD4 SULF1 FZD5 PRAMEF14 PRAMEF15 PRKDC PRAMEF4 DND1 PRAMEF13 PRAMEF11 | 1.05e-03 | 1235 | 53 | 10 | GO:0003006 |
| GeneOntologyBiologicalProcess | regulation of establishment of planar polarity | 1.08e-03 | 19 | 53 | 2 | GO:0090175 | |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 1.75e-09 | 47 | 52 | 6 | GO:0031462 | |
| GeneOntologyCellularComponent | cullin-RING ubiquitin ligase complex | 1.40e-05 | 212 | 52 | 6 | GO:0031461 | |
| GeneOntologyCellularComponent | ubiquitin ligase complex | 2.31e-04 | 352 | 52 | 6 | GO:0000151 | |
| GeneOntologyCellularComponent | coated vesicle | 2.61e-04 | 360 | 52 | 6 | GO:0030135 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 3.02e-04 | 237 | 52 | 5 | GO:0030136 | |
| GeneOntologyCellularComponent | transferase complex | TAF6L PRAMEF9 PRAMEF14 PRAMEF15 PRKAR1A PRKDC PRAMEF4 PRAMEF13 PRAMEF11 | 5.55e-04 | 963 | 52 | 9 | GO:1990234 |
| GeneOntologyCellularComponent | intracellular protein-containing complex | TAF6L PRAMEF9 PRAMEF14 PRAMEF15 PRKAR1A PRKDC PRAMEF4 PRAMEF13 PRAMEF11 | 5.94e-04 | 972 | 52 | 9 | GO:0140535 |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle membrane | 1.00e-03 | 79 | 52 | 3 | GO:0030669 | |
| GeneOntologyCellularComponent | acrosomal vesicle | 1.71e-03 | 206 | 52 | 4 | GO:0001669 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 1.90e-03 | 212 | 52 | 4 | GO:0030666 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle | 2.04e-03 | 101 | 52 | 3 | GO:0045334 | |
| MousePheno | abnormal spermatogonia proliferation | 3.02e-07 | 47 | 43 | 5 | MP:0002685 | |
| MousePheno | abnormal duodenum morphology | 1.44e-06 | 64 | 43 | 5 | MP:0003271 | |
| MousePheno | increased circulating amylase level | 1.58e-06 | 119 | 43 | 6 | MP:0008806 | |
| MousePheno | abnormal tail morphology | FZD7 BMP2 FZD3 PRAMEF14 PRAMEF15 PRKAR1A PRAMEF4 PRAMEF13 PRAMEF11 | 2.97e-06 | 403 | 43 | 9 | MP:0002111 |
| MousePheno | abnormal jejunum morphology | 7.23e-06 | 41 | 43 | 4 | MP:0004002 | |
| MousePheno | abnormal circulating amylase level | 7.60e-06 | 156 | 43 | 6 | MP:0008804 | |
| MousePheno | abnormal cecum morphology | 1.25e-05 | 99 | 43 | 5 | MP:0000494 | |
| MousePheno | abnormal small intestine morphology | 2.14e-05 | 187 | 43 | 6 | MP:0000496 | |
| MousePheno | enlarged urinary bladder | 2.70e-05 | 116 | 43 | 5 | MP:0011874 | |
| MousePheno | increased kidney weight | 7.85e-05 | 145 | 43 | 5 | MP:0003917 | |
| MousePheno | increased cellular sensitivity to X-ray irradiation | 9.19e-05 | 5 | 43 | 2 | MP:0002879 | |
| MousePheno | abnormal large intestine morphology | 1.85e-04 | 276 | 43 | 6 | MP:0000489 | |
| MousePheno | abnormal lens morphology | SND1 FZD5 PRAMEF14 PRAMEF15 LRP1 PRAMEF4 PRAMEF13 PRAMEF11 OPLAH | 2.26e-04 | 699 | 43 | 9 | MP:0001303 |
| MousePheno | increased male germ cell apoptosis | 2.72e-04 | 189 | 43 | 5 | MP:0014052 | |
| MousePheno | abnormal vitreous body morphology | 3.02e-04 | 429 | 43 | 7 | MP:0002699 | |
| MousePheno | digestive/alimentary phenotype | FZD4 DSG2 FZD5 PRAMEF15 PRKAR1A CDHR5 FADS6 PRKDC PRAMEF4 PRAMEF13 FZD2 PRAMEF11 ITPKB | 3.95e-04 | 1500 | 43 | 13 | MP:0005381 |
| MousePheno | abnormal kidney weight | 4.22e-04 | 208 | 43 | 5 | MP:0002707 | |
| MousePheno | cataract | 7.30e-04 | 497 | 43 | 7 | MP:0001304 | |
| MousePheno | abnormal male germ cell apoptosis | 7.50e-04 | 236 | 43 | 5 | MP:0008280 | |
| MousePheno | absent T cells | 8.22e-04 | 14 | 43 | 2 | MP:0008070 | |
| MousePheno | azoospermia | 8.71e-04 | 244 | 43 | 5 | MP:0005159 | |
| MousePheno | abnormal male germ cell physiology | 8.71e-04 | 244 | 43 | 5 | MP:0020362 | |
| MousePheno | decreased testis weight | 8.80e-04 | 370 | 43 | 6 | MP:0004852 | |
| MousePheno | abnormal urinary bladder morphology | 9.20e-04 | 247 | 43 | 5 | MP:0000538 | |
| MousePheno | abnormal stomach morphology | 9.37e-04 | 248 | 43 | 5 | MP:0000470 | |
| MousePheno | abnormal digestive system morphology | FZD4 FZD5 PRAMEF15 PRKAR1A FADS6 PRKDC PRAMEF4 PRAMEF13 FZD2 PRAMEF11 ITPKB | 9.83e-04 | 1233 | 43 | 11 | MP:0000462 |
| MousePheno | absent gametes | 1.08e-03 | 256 | 43 | 5 | MP:0001117 | |
| Domain | Frizzled | 1.53e-16 | 11 | 48 | 7 | IPR000539 | |
| Domain | Frizzled | 1.53e-16 | 11 | 48 | 7 | PF01534 | |
| Domain | Frizzled | 1.53e-16 | 11 | 48 | 7 | SM01330 | |
| Domain | Frizzled/SFRP | 5.27e-15 | 16 | 48 | 7 | IPR015526 | |
| Domain | FRI | 3.54e-14 | 20 | 48 | 7 | SM00063 | |
| Domain | - | 5.30e-14 | 21 | 48 | 7 | 1.10.2000.10 | |
| Domain | Frizzled_dom | 1.57e-13 | 24 | 48 | 7 | IPR020067 | |
| Domain | FZ | 1.57e-13 | 24 | 48 | 7 | PS50038 | |
| Domain | Fz | 1.57e-13 | 24 | 48 | 7 | PF01392 | |
| Domain | GPCR_2-like | 1.63e-10 | 60 | 48 | 7 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 1.84e-10 | 61 | 48 | 7 | PS50261 | |
| Domain | GPCR_2_secretin-like | 9.40e-09 | 60 | 48 | 6 | IPR000832 | |
| Domain | PRAME_family | 1.45e-07 | 19 | 48 | 4 | IPR026271 | |
| Domain | Pentatricopeptide_repeat | 1.58e-03 | 23 | 48 | 2 | IPR002885 | |
| Domain | - | 9.20e-03 | 321 | 48 | 4 | 3.80.10.10 | |
| Domain | L_dom-like | 9.90e-03 | 328 | 48 | 4 | IPR032675 | |
| Domain | - | 1.36e-02 | 69 | 48 | 2 | 1.10.20.10 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_SOST_LRP4 | 2.88e-15 | 14 | 40 | 7 | M47834 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT5A_ROR_SIGNALING_PATHWAY | 9.55e-15 | 16 | 40 | 7 | M47823 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_LGR_RSPO | 4.18e-14 | 19 | 40 | 7 | M47833 | |
| Pathway | KEGG_BASAL_CELL_CARCINOMA | 2.21e-12 | 55 | 40 | 8 | M17807 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 6.69e-12 | 36 | 40 | 7 | M39699 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 3.02e-11 | 44 | 40 | 7 | MM15878 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 3.26e-11 | 118 | 40 | 9 | M39852 | |
| Pathway | KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 3.57e-11 | 45 | 40 | 7 | M47412 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY | 4.20e-11 | 46 | 40 | 7 | M47409 | |
| Pathway | PID_WNT_SIGNALING_PATHWAY | 1.27e-10 | 28 | 40 | 6 | M77 | |
| Pathway | REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS | 2.95e-10 | 60 | 40 | 7 | MM15150 | |
| Pathway | REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS | 4.70e-10 | 64 | 40 | 7 | M27396 | |
| Pathway | WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS | 5.87e-10 | 66 | 40 | 7 | M39642 | |
| Pathway | REACTOME_PCP_CE_PATHWAY | 3.58e-09 | 85 | 40 | 7 | MM15041 | |
| Pathway | WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY | 3.58e-09 | 85 | 40 | 7 | M48315 | |
| Pathway | WNT_SIGNALING | 4.95e-09 | 89 | 40 | 7 | M5493 | |
| Pathway | REACTOME_PCP_CE_PATHWAY | 6.26e-09 | 92 | 40 | 7 | M27322 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 7.28e-09 | 94 | 40 | 7 | M797 | |
| Pathway | KEGG_MELANOGENESIS | 1.21e-08 | 101 | 40 | 7 | M7761 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY | 1.21e-08 | 101 | 40 | 7 | MM15829 | |
| Pathway | WP_WNT_SIGNALING_AND_PLURIPOTENCY | 1.21e-08 | 101 | 40 | 7 | M39387 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 1.37e-08 | 161 | 40 | 8 | M39770 | |
| Pathway | WP_WNT_SIGNALING | 1.75e-08 | 61 | 40 | 6 | MM15893 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY | 2.19e-08 | 110 | 40 | 7 | MM15977 | |
| Pathway | WP_ESC_PLURIPOTENCY_PATHWAYS | 3.17e-08 | 116 | 40 | 7 | MM15863 | |
| Pathway | WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS | 3.37e-08 | 117 | 40 | 7 | M39530 | |
| Pathway | REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING | 4.76e-08 | 123 | 40 | 7 | MM14988 | |
| Pathway | WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS | 1.29e-07 | 17 | 40 | 4 | M39525 | |
| Pathway | REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING | 1.55e-07 | 146 | 40 | 7 | M27288 | |
| Pathway | WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA | 1.72e-07 | 89 | 40 | 6 | M39563 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 1.95e-07 | 151 | 40 | 7 | M19428 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 2.23e-07 | 154 | 40 | 7 | M39739 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 2.40e-07 | 325 | 40 | 9 | M12868 | |
| Pathway | WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER | 3.07e-07 | 98 | 40 | 6 | M39731 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 7.14e-07 | 113 | 40 | 6 | M39669 | |
| Pathway | REACTOME_SIGNALING_BY_RNF43_MUTANTS | 1.17e-06 | 8 | 40 | 3 | M27433 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 4.27e-06 | 239 | 40 | 7 | MM14756 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 7.61e-06 | 261 | 40 | 7 | M42565 | |
| Pathway | REACTOME_CA2_PATHWAY | 7.61e-06 | 45 | 40 | 4 | MM15040 | |
| Pathway | WP_GPCRS_NONODORANT | 8.62e-06 | 266 | 40 | 7 | MM15843 | |
| Pathway | WP_CANCER_PATHWAYS | 9.47e-06 | 507 | 40 | 9 | M48302 | |
| Pathway | REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION | 2.33e-05 | 20 | 40 | 3 | MM15155 | |
| Pathway | REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION | 2.72e-05 | 21 | 40 | 3 | M27401 | |
| Pathway | REACTOME_CA2_PATHWAY | 2.75e-05 | 62 | 40 | 4 | M27321 | |
| Pathway | WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS | 3.21e-05 | 326 | 40 | 7 | M39379 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 3.47e-05 | 330 | 40 | 7 | M7847 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 7.96e-05 | 158 | 40 | 5 | MM14791 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 9.00e-05 | 31 | 40 | 3 | M27400 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 9.00e-05 | 31 | 40 | 3 | MM15154 | |
| Pathway | PID_WNT_NONCANONICAL_PATHWAY | 9.92e-05 | 32 | 40 | 3 | M23 | |
| Pathway | REACTOME_SIGNALING_BY_WNT_IN_CANCER | 1.19e-04 | 34 | 40 | 3 | M27405 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 1.22e-04 | 702 | 40 | 9 | M746 | |
| Pathway | WP_GPCRS_OTHER | 1.53e-04 | 96 | 40 | 4 | MM15939 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 2.87e-04 | 463 | 40 | 7 | M507 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 4.85e-04 | 233 | 40 | 5 | M27099 | |
| Pathway | REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2 | 5.09e-04 | 12 | 40 | 2 | MM15163 | |
| Pathway | REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2 | 6.00e-04 | 13 | 40 | 2 | M27415 | |
| Pathway | WP_MESODERMAL_COMMITMENT_PATHWAY | 9.00e-04 | 153 | 40 | 4 | M39546 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 1.38e-03 | 439 | 40 | 6 | M42563 | |
| Pathway | REACTOME_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES | 4.16e-03 | 34 | 40 | 2 | M27461 | |
| Pubmed | Expression of Frizzled genes in developing and postnatal hair follicles. | 1.51e-18 | 10 | 53 | 7 | 15245425 | |
| Pubmed | Essential roles of mesenchyme-derived beta-catenin in mouse Müllerian duct morphogenesis. | 1.51e-18 | 10 | 53 | 7 | 17532316 | |
| Pubmed | Frizzled-9 impairs acetylcholine receptor clustering in skeletal muscle cells. | 4.15e-18 | 11 | 53 | 7 | 24860427 | |
| Pubmed | Molecular determinants of WNT9b responsiveness in nephron progenitor cells. | 4.15e-18 | 11 | 53 | 7 | 30978219 | |
| Pubmed | 4.15e-18 | 11 | 53 | 7 | 17582687 | ||
| Pubmed | 4.15e-18 | 11 | 53 | 7 | 17576136 | ||
| Pubmed | Differential expression of the Wnt putative receptors Frizzled during mouse somitogenesis. | 2.61e-16 | 8 | 53 | 6 | 10559494 | |
| Pubmed | 2.12e-15 | 22 | 53 | 7 | 17064353 | ||
| Pubmed | A role for Wnt/beta-catenin signaling in lens epithelial differentiation. | 5.95e-15 | 25 | 53 | 7 | 12812787 | |
| Pubmed | 1.92e-14 | 29 | 53 | 7 | 18364260 | ||
| Pubmed | Deterministic and stochastic allele specific gene expression in single mouse blastomeres. | FZD1 FZD4 FZD7 FZD8 BMP2 FZD3 FZD5 PRAMEF14 PRAMEF15 PRAMEF4 PRAMEF13 FZD2 PRAMEF11 | 5.92e-14 | 424 | 53 | 13 | 21731673 |
| Pubmed | 1.02e-13 | 36 | 53 | 7 | 24151333 | ||
| Pubmed | Mapping of Wnt-Frizzled interactions by multiplex CRISPR targeting of receptor gene families. | 1.14e-13 | 17 | 53 | 6 | 28733458 | |
| Pubmed | 1.26e-13 | 37 | 53 | 7 | 15342465 | ||
| Pubmed | Patterns of Wnt/Fzd/LRP gene expression during embryonic hematopoiesis. | 1.26e-13 | 37 | 53 | 7 | 18800919 | |
| Pubmed | 1.42e-13 | 7 | 53 | 5 | 15370539 | ||
| Pubmed | Wnt11 promotes cardiomyocyte development by caspase-mediated suppression of canonical Wnt signals. | 1.54e-13 | 38 | 53 | 7 | 21041481 | |
| Pubmed | Tissue-specific requirements of beta-catenin in external genitalia development. | 1.54e-13 | 38 | 53 | 7 | 18635608 | |
| Pubmed | Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells. | 2.50e-13 | 19 | 53 | 6 | 21623369 | |
| Pubmed | 3.78e-13 | 8 | 53 | 5 | 19388021 | ||
| Pubmed | Stromal R-spondin orchestrates gastric epithelial stem cells and gland homeostasis. | 7.58e-13 | 47 | 53 | 7 | 28813421 | |
| Pubmed | 7.58e-13 | 47 | 53 | 7 | 18351675 | ||
| Pubmed | 7.58e-13 | 47 | 53 | 7 | 33141892 | ||
| Pubmed | A novel frizzled gene identified in human esophageal carcinoma mediates APC/beta-catenin signals. | 8.49e-13 | 9 | 53 | 5 | 9707618 | |
| Pubmed | Wnt antagonist SFRP3 inhibits the differentiation of mouse hepatic progenitor cells. | 1.03e-12 | 49 | 53 | 7 | 19562671 | |
| Pubmed | 1.20e-12 | 50 | 53 | 7 | 27510977 | ||
| Pubmed | 1.23e-12 | 24 | 53 | 6 | 9096311 | ||
| Pubmed | 1.23e-12 | 24 | 53 | 6 | 8626800 | ||
| Pubmed | 1.76e-11 | 36 | 53 | 6 | 12412008 | ||
| Pubmed | Integrated analysis of Wnt signalling system component gene expression. | 2.10e-11 | 37 | 53 | 6 | 35831952 | |
| Pubmed | 2.40e-11 | 5 | 53 | 4 | 10395542 | ||
| Pubmed | 5.71e-11 | 18 | 53 | 5 | 23894331 | ||
| Pubmed | Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos. | 5.71e-11 | 18 | 53 | 5 | 12890732 | |
| Pubmed | Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes. | 5.71e-11 | 18 | 53 | 5 | 29731491 | |
| Pubmed | 5.71e-11 | 18 | 53 | 5 | 14675769 | ||
| Pubmed | Direct interaction between NHERF1 and Frizzled regulates β-catenin signaling. | 7.19e-11 | 6 | 53 | 4 | 20802536 | |
| Pubmed | Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways. | 7.75e-11 | 19 | 53 | 5 | 28604677 | |
| Pubmed | 8.57e-11 | 90 | 53 | 7 | 19515997 | ||
| Pubmed | 1.03e-10 | 20 | 53 | 5 | 26694250 | ||
| Pubmed | 1.03e-10 | 20 | 53 | 5 | 16580637 | ||
| Pubmed | Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells. | 1.03e-10 | 20 | 53 | 5 | 21425410 | |
| Pubmed | Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. | 1.68e-10 | 7 | 53 | 4 | 9192640 | |
| Pubmed | 1.68e-10 | 7 | 53 | 4 | 15195140 | ||
| Pubmed | 1.75e-10 | 22 | 53 | 5 | 31729367 | ||
| Pubmed | 2.23e-10 | 23 | 53 | 5 | 19480014 | ||
| Pubmed | 3.51e-10 | 25 | 53 | 5 | 37451217 | ||
| Pubmed | Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. | 3.51e-10 | 25 | 53 | 5 | 12620990 | |
| Pubmed | Mesenchymal Hox6 function is required for mouse pancreatic endocrine cell differentiation. | 3.96e-10 | 59 | 53 | 6 | 26450967 | |
| Pubmed | Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3. | 4.35e-10 | 26 | 53 | 5 | 18500982 | |
| Pubmed | 5.51e-10 | 117 | 53 | 7 | 17145500 | ||
| Pubmed | A role for the Wnt gene family in hematopoiesis: expansion of multilineage progenitor cells. | 6.02e-10 | 9 | 53 | 4 | 9160667 | |
| Pubmed | Direct interaction of Frizzled-1, -2, -4, and -7 with PDZ domains of PSD-95. | 6.02e-10 | 9 | 53 | 4 | 12067714 | |
| Pubmed | 6.48e-10 | 28 | 53 | 5 | 25089626 | ||
| Pubmed | Thirteen Ovary-Enriched Genes Are Individually Not Essential for Female Fertility in Mice. | 9.37e-10 | 30 | 53 | 5 | 38786026 | |
| Pubmed | LSM14B is essential for oocyte meiotic maturation by regulating maternal mRNA storage and clearance. | 1.32e-09 | 32 | 53 | 5 | 37889087 | |
| Pubmed | 2.12e-09 | 35 | 53 | 5 | 19389355 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 9813155 | ||
| Pubmed | Frizzled proteins are colonic epithelial receptors for C. difficile toxin B. | 3.34e-09 | 3 | 53 | 3 | 27680706 | |
| Pubmed | 6.48e-09 | 15 | 53 | 4 | 15617677 | ||
| Pubmed | 8.85e-09 | 46 | 53 | 5 | 17287250 | ||
| Pubmed | Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse. | 1.13e-08 | 17 | 53 | 4 | 23565261 | |
| Pubmed | 1.13e-08 | 17 | 53 | 4 | 37781892 | ||
| Pubmed | Cooperative and independent functions of FGF and Wnt signaling during early inner ear development. | 1.13e-08 | 17 | 53 | 4 | 26443994 | |
| Pubmed | WNT signaling affects gene expression in the ventral diencephalon and pituitary gland growth. | 1.36e-08 | 50 | 53 | 5 | 18351662 | |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | 1.36e-08 | 50 | 53 | 5 | 31806660 | |
| Pubmed | Pramel15 facilitates zygotic nuclear DNMT1 degradation and DNA demethylation. | 1.45e-08 | 18 | 53 | 4 | 39181896 | |
| Pubmed | 2.92e-08 | 58 | 53 | 5 | 31598710 | ||
| Pubmed | 3.33e-08 | 5 | 53 | 3 | 19543507 | ||
| Pubmed | 3.33e-08 | 5 | 53 | 3 | 18256285 | ||
| Pubmed | SND1 PRAMEF14 GPATCH1 PRAMEF15 PRAMEF4 DND1 PRAMEF13 PRAMEF11 | 5.43e-08 | 347 | 53 | 8 | 16033648 | |
| Pubmed | 6.66e-08 | 6 | 53 | 3 | 36867021 | ||
| Pubmed | 8.22e-08 | 27 | 53 | 4 | 17804636 | ||
| Pubmed | Wnt signaling is required for thymocyte development and activates Tcf-1 mediated transcription. | 1.16e-07 | 7 | 53 | 3 | 11265645 | |
| Pubmed | 1.16e-07 | 7 | 53 | 3 | 15923619 | ||
| Pubmed | 1.86e-07 | 8 | 53 | 3 | 15035989 | ||
| Pubmed | 1.86e-07 | 8 | 53 | 3 | 19643732 | ||
| Pubmed | 2.79e-07 | 9 | 53 | 3 | 23095888 | ||
| Pubmed | ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. | 5.47e-07 | 11 | 53 | 3 | 22575959 | |
| Pubmed | 5.47e-07 | 11 | 53 | 3 | 25294940 | ||
| Pubmed | Role of chromatin remodeling gene Cecr2 in neurulation and inner ear development. | 9.45e-07 | 13 | 53 | 3 | 21246654 | |
| Pubmed | 9.45e-07 | 13 | 53 | 3 | 22266179 | ||
| Pubmed | 2.06e-06 | 59 | 53 | 4 | 11279525 | ||
| Pubmed | Mesenchymal Wnt signaling promotes formation of sternum and thoracic body wall. | 2.24e-06 | 17 | 53 | 3 | 25727890 | |
| Pubmed | Aberrant DNA-PKcs and ERGIC1 expression may be involved in initiation of gastric cancer. | 2.28e-06 | 2 | 53 | 2 | 28970727 | |
| Pubmed | Melanocyte stem cells express receptors for canonical Wnt-signaling pathway on their surface. | 2.28e-06 | 2 | 53 | 2 | 20450888 | |
| Pubmed | Structural basis for recognition of frizzled proteins by Clostridium difficile toxin B. | 2.28e-06 | 2 | 53 | 2 | 29748286 | |
| Pubmed | Frizzled-4 is required for normal bone acquisition despite compensation by Frizzled-8. | 2.28e-06 | 2 | 53 | 2 | 31985040 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 20189955 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 32686190 | ||
| Pubmed | 5.04e-06 | 22 | 53 | 3 | 12815618 | ||
| Pubmed | Modulation of apical constriction by Wnt signaling is required for lung epithelial shape transition. | 5.04e-06 | 22 | 53 | 3 | 27913639 | |
| Pubmed | Motor neurons with axial muscle projections specified by Wnt4/5 signaling. | 5.04e-06 | 22 | 53 | 3 | 19285468 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 11520064 | ||
| Pubmed | Frizzled7 functions as a Wnt receptor in intestinal epithelial Lgr5(+) stem cells. | 6.83e-06 | 3 | 53 | 2 | 25892522 | |
| Pubmed | Murine Frizzled-1 behaves as an antagonist of the canonical Wnt/beta-catenin signaling. | 6.83e-06 | 3 | 53 | 2 | 14627707 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 35296808 | ||
| Pubmed | Wnt2b controls retinal cell differentiation at the ciliary marginal zone. | 6.83e-06 | 3 | 53 | 2 | 12490564 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 28600348 | ||
| Pubmed | The Maternal Microbiome Programs the m6A Epitranscriptome of the Mouse Fetal Brain and Intestine. | 7.51e-06 | 25 | 53 | 3 | 35874829 | |
| Pubmed | 8.47e-06 | 26 | 53 | 3 | 23827310 | ||
| Interaction | SCGB1C1 interactions | 4.04e-06 | 13 | 50 | 3 | int:SCGB1C1 | |
| Interaction | PRAMEF4 interactions | 1.81e-05 | 3 | 50 | 2 | int:PRAMEF4 | |
| Interaction | WNT5A interactions | 2.57e-05 | 69 | 50 | 4 | int:WNT5A | |
| Interaction | UPK1A interactions | 3.46e-05 | 150 | 50 | 5 | int:UPK1A | |
| Interaction | OR1D4 interactions | 3.59e-05 | 26 | 50 | 3 | int:OR1D4 | |
| Cytoband | 1p36.21 | PRAMEF25 PRAMEF9 PRAMEF14 PRAMEF15 PRAMEF4 PRAMEF13 PRAMEF11 | 9.53e-13 | 63 | 53 | 7 | 1p36.21 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | PRAMEF25 PRAMEF9 PRAMEF14 PRAMEF15 PADI6 PRAMEF4 TTLL10 PRAMEF13 PRAMEF11 | 8.17e-08 | 681 | 53 | 9 | chr1p36 |
| GeneFamily | G protein-coupled receptors, Class F frizzled | 4.03e-17 | 11 | 39 | 7 | 286 | |
| GeneFamily | PRAME family | PRAMEF25 PRAMEF9 PRAMEF14 PRAMEF15 PRAMEF4 PRAMEF13 PRAMEF11 | 4.14e-14 | 24 | 39 | 7 | 686 |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 2.80e-07 | 135 | 52 | 6 | M5825 | |
| Coexpression | GU_PDEF_TARGETS_UP | 2.97e-07 | 71 | 52 | 5 | M3955 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_DN | 3.71e-07 | 232 | 52 | 7 | MM1019 | |
| Coexpression | KOHOUTEK_CCNT2_TARGETS | 5.77e-07 | 81 | 52 | 5 | MM938 | |
| Coexpression | KINNEY_DNMT1_METHYLATION_TARGETS | 6.11e-07 | 34 | 52 | 4 | MM955 | |
| Coexpression | MORI_SMALL_PRE_BII_LYMPHOCYTE_UP | 1.49e-06 | 98 | 52 | 5 | MM592 | |
| Coexpression | HUANG_GATA2_TARGETS_DN | 1.49e-06 | 98 | 52 | 5 | MM942 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS | 1.51e-06 | 180 | 52 | 6 | MM612 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED | 5.03e-06 | 57 | 52 | 4 | MM1262 | |
| Coexpression | INGRAM_SHH_TARGETS_UP | 1.45e-05 | 156 | 52 | 5 | MM550 | |
| Coexpression | MIKKELSEN_ES_ICP_WITH_H3K4ME3 | SULF1 PRAMEF14 PRAMEF15 LRP1 ARHGAP30 PRAMEF4 PRAMEF13 PRAMEF11 OPLAH | 2.67e-05 | 807 | 52 | 9 | MM855 |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 3.51e-05 | 32 | 52 | 3 | M5903 | |
| Coexpression | FOSTER_KDM1A_TARGETS_UP | 3.81e-05 | 317 | 52 | 6 | MM956 | |
| Coexpression | DESCARTES_ORGANOGENESIS_SCHWANN_CELL_PRECURSOR | 4.33e-05 | 98 | 52 | 4 | MM3656 | |
| Coexpression | GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP | 4.78e-05 | 200 | 52 | 5 | M8482 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS | TBXAS1 FZD3 PRAMEF14 PRAMEF15 PRKAR1A SMIM20 PRAMEF4 PRAMEF13 PRAMEF11 | 4.83e-05 | 871 | 52 | 9 | MM1005 |
| Coexpression | SANSOM_APC_TARGETS | 1.24e-04 | 245 | 52 | 5 | MM735 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 1.25e-04 | 767 | 52 | 8 | M39209 | |
| Coexpression | ZHAN_MULTIPLE_MYELOMA_MS_UP | 1.35e-04 | 50 | 52 | 3 | M19632 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | 1.67e-04 | 261 | 52 | 5 | MM1277 | |
| Coexpression | VILLANUEVA_LIVER_CANCER_KRT19_DN | 2.69e-04 | 63 | 52 | 3 | M373 | |
| Coexpression | HU_FETAL_RETINA_RPE | 2.76e-04 | 291 | 52 | 5 | M39271 | |
| Coexpression | KUMAR_TARGETS_OF_MLL_AF9_FUSION | 3.01e-04 | 463 | 52 | 6 | MM1011 | |
| Coexpression | JARDIM_PERASSI_TRIPLE_NEGATIVE_BREAST_CANCER_MOUSE_XENOGRAFT_MELATONIN_DN | 3.46e-04 | 14 | 52 | 2 | MM453 | |
| Coexpression | YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN | 3.64e-04 | 309 | 52 | 5 | MM1244 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | 3.75e-04 | 681 | 52 | 7 | M5314 | |
| Coexpression | WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN | 3.83e-04 | 71 | 52 | 3 | M707 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Monophasic_Synovial_Sarcoma-5|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 4.64e-06 | 93 | 53 | 4 | 3e05ea0f8f4a7cdb78a596f47d563dc3c94d4d8e | |
| Drug | A 172 | 1.72e-10 | 70 | 50 | 7 | CID000014025 | |
| Drug | Prestwick_517 | 1.19e-07 | 106 | 50 | 6 | CID000003804 | |
| Drug | AC1L9M5J | 5.17e-07 | 221 | 50 | 7 | CID000448615 | |
| Drug | clofazimine | 1.02e-06 | 35 | 50 | 4 | CID000002794 | |
| Disease | Colorectal Carcinoma | 6.56e-04 | 702 | 45 | 6 | C0009402 | |
| Disease | eosinophil percentage of leukocytes | 9.00e-04 | 746 | 45 | 6 | EFO_0007991 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LVMLPFDLRIPFARY | 1111 | Q9P2K8 | |
| DPGRPERLVFKMRFY | 161 | Q9UBZ4 | |
| RLDRPLDFYERPNMT | 186 | Q9HBB8 | |
| RDAVVPPYMLDLYRR | 71 | P12643 | |
| EESRNRMLELLYPFP | 156 | A0A1B0GVH7 | |
| FMRENRLTPFLDPRY | 421 | Q9NVM9 | |
| VPYVMVRERESFLAP | 1011 | Q14126 | |
| KRSFARPYFPDLLRM | 606 | Q6TGC4 | |
| PRYPLMDRFEEVYFR | 521 | Q96F46 | |
| LLRSERPPIFEIRMY | 781 | Q07954 | |
| ELPRDYRPVHYFRPM | 366 | Q9BRR8 | |
| MPFDFRRFDIYRKVP | 1 | Q969X5 | |
| YLVDMQRFRYPERPI | 266 | Q14332 | |
| ELFPPLFMEAFSRRR | 36 | P0DUQ1 | |
| YRIPLPMTVEEYRIA | 6 | Q9BZ72 | |
| YLVDMRRFSYPERPI | 341 | Q9UP38 | |
| SRFSYPERPIIFLSM | 246 | Q9ULV1 | |
| TFLIDMERFRYPERP | 256 | Q13467 | |
| MERFRYPERPIIFLS | 261 | Q13467 | |
| LVDMRRFSYPERPII | 276 | O75084 | |
| IDMERFKYPERPIIF | 301 | Q9H461 | |
| IFTVFRILIRPEMFP | 951 | Q8N1I0 | |
| PLFQRVGRLYEFRLM | 76 | Q8IYX4 | |
| MAEERPPRLVDYFVV | 1 | O75064 | |
| IDVTRFRYPERPIIF | 226 | Q9NPG1 | |
| ARPERPMAFLREYFE | 41 | P10644 | |
| FLRRYEEFMVQAPPI | 336 | Q8N9I5 | |
| LPRVLYLPLFMEAFR | 31 | Q5VWM6 | |
| ELPVPNYRTLEFLMR | 136 | Q7Z6I6 | |
| QYLPRTSEPREMLFE | 551 | Q6PCB5 | |
| FVTEELFQRLPRRMP | 1066 | P26640 | |
| MRPAREGELYFPEDR | 91 | Q9Y6J9 | |
| DRLRPLSYPMTDVFL | 71 | P17081 | |
| PYCLRIEPDMRRFFE | 976 | Q07890 | |
| LPRVLYLPLFMEAFR | 31 | Q5SWL7 | |
| RVYERILFMPRPDYA | 686 | A6NCM1 | |
| ILFMPRPDYASRYVL | 691 | A6NCM1 | |
| DRLMVDVLRPFVPAY | 701 | P27987 | |
| YMREFGFVIPERPVV | 616 | O14841 | |
| ELFPPLFMEAFSRRR | 36 | A6NGN4 | |
| AFYPIYFRPLMRLEE | 21 | Q8N5G0 | |
| RQRVLEGRFRIPYFM | 226 | Q9H0K1 | |
| RPLYDIPYMFEAREF | 391 | Q7KZF4 | |
| FMSAYEQRIEPPDRR | 151 | Q15428 | |
| TIFPVVPRLLNRMYD | 361 | Q9UKU0 | |
| ELFPPLFMEAFSRRR | 36 | O60810 | |
| VIAETLRMYPPAFRF | 396 | P24557 | |
| LRMYPPAFRFTREAA | 401 | P24557 | |
| ELFPPLFMEAFSRRR | 36 | P0DUQ2 | |
| MIRSIDRPFIDPQRY | 951 | Q9P253 | |
| ELFPPLFMEAFSRRR | 36 | O60813 | |
| RRYNFPVEVEVPMER | 1986 | P78527 | |
| FMGVYLPESRRPLFI | 466 | Q92536 | |
| SMPYDFDIRVPFFIR | 331 | Q8IWU6 | |
| GYLRPQRVLRMEEFF | 271 | Q6ZVT0 | |
| RPLIMIRAFRIYFRF | 146 | Q8IZF0 |